Xilin Zhou (Ping Zhang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Cardiovascular Disease

Health Insurance

Glycemic Control

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yixue Shao, Yu Wang, Elizabeth Bigman, Giuseppina Imperatore, Christopher Holliday, Xilin Zhou
Lifetime Medical Spending Attributed to Incident Type 2 Diabetes in Medicare Beneficiaries: A Longitudinal Study Using 1999-2019 National Medicare Claims. Diabetes care 47 (8) (2024)
Yu Wang, Xilin Zhou, Xilin Zhou, Deborah Rolka, Giuseppina Imperatore
Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes care 47 (3) (2024)
Yixue Shao, Yu Wang, Elizabeth Bigman, Giuseppina Imperatore, Christopher Holliday, Xilin Zhou
Lifetime Medical Spending Attributed to Incident Type 2 Diabetes in Medicare Beneficiaries: A Longitudinal Study Using 1999-2019 National Medicare Claims. Diabetes care 47 (8) (2024)
Olga A Khavjou, Minglu Sun, Sophia R D'Angelo, Simon J Neuwahl, Thomas J Hoerger, Pyone Cho, Kristopher Myers, Xilin Zhou
Economic Costs Attributed to Diagnosed Diabetes in Each U.S. State and the District of Columbia: 2021. Diabetes care (2024)
Yu Wang, Xilin Zhou, Xilin Zhou, Deborah Rolka, Giuseppina Imperatore
Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes care 47 (3) (2024)
Yu Wang, Xilin Zhou, Xilin Zhou, Deborah Rolka, Giuseppina Imperatore
Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes care (2024)
Yu Wang, Xilin Zhou, Xilin Zhou, Deborah Rolka, Giuseppina Imperatore
Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes care 47 (3) (2024)
Yixue Shao, Yu Wang, Elizabeth Bigman, Giuseppina Imperatore, Christopher Holliday, Xilin Zhou
Lifetime Medical Spending Attributed to Incident Type 2 Diabetes in Medicare Beneficiaries: A Longitudinal Study Using 1999-2019 National Medicare Claims. Diabetes care (2024)
Joohyun Park, Elizabeth Bigman, Xilin Zhou
Productivity Loss and Medical Costs Associated With Type 2 Diabetes Among Employees Aged 18-64 Years With Large Employer-Sponsored Insurance. Diabetes care 45 (11) (2022)
Yu Wang, Xilin Zhou, Hui Shao, Linda J Andes, Giuseppina Imperatore
Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes. Diabetes care (2022)
Yu Wang, Xilin Zhou, Hui Shao, Linda J Andes, Giuseppina Imperatore
Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 2 Diabetes. Diabetes care 45 (11) (2022)
Xilin Zhou, Karen R Siegel, Boon Peng Ng, Shawn Jawanda, Krista K Proia, Xuanping Zhang, Ann L Albright, Xilin Zhou
Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes care 43 (7) (2021)
Xilin Zhou, Xilin Zhou
Response to Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593-1616. Diabetes care 43 (12) (2021)
Yu Wang, Joohyun Park, Rui Li, Elizabeth Luman, Xilin Zhou
National Trends in Out-of-Pocket Costs Among U.S. Adults With Diabetes Aged 18-64 Years: 2001-2017. Diabetes care 44 (11) (2021)
Joohyun Park, Xilin Zhou, Yu Wang, Xilin Zhou, Kevin A Look, Elizabeth T Bigman
High Out-of-pocket Health Care Cost Burden Among Medicare Beneficiaries With Diabetes, 1999-2017. Diabetes care 44 (8) (2021)
Catherine E Barrett, Joohyun Park, Lyudmyla Kompaniyets, James Baggs, Yiling J Cheng, Xilin Zhou, Giuseppina Imperatore, Meda E Pavkov
Intensive Care Unit Admission, Mechanical Ventilation, and Mortality Among Patients With Type 1 Diabetes Hospitalized for COVID-19 in the U.S. Diabetes care 44 (8) (2021)
Michael Laxy, Xilin Zhou, Stephen R Benoit, Giuseppina Imperatore, Yiling J Cheng, Edward W Gregg, Shuang Yang, Stephen R Benoit
Trends in Total and Out-of-pocket Payments for Insulin Among Privately Insured U.S. Adults With Diabetes From 2005 to 2018. Diabetes care (2021)
Karen R Siegel, Mohammed K Ali, Xilin Zhou, Boon Peng Ng, Shawn Jawanda, Krista Proia, Xuanping Zhang, Edward W Gregg, Ann L Albright, Xilin Zhou
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? Diabetes care 43 (7) (2021)
Xilin Zhou, Sundar S Shrestha, Stephen R Benoit, Xilin Zhou
Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017. Diabetes care 43 (10) (2020)
Xilin Zhou, Karen M Atkinson, George A Bray, Haiying Chen, Jeanne M Clark, Mace Coday, Gareth R Dutton, Caitlin Egan, Mark A Espeland, Mary Evans, John P Foreyt, Frank L Greenway, Edward W Gregg, Helen P Hazuda, James O Hill, Edward S Horton, Edward S Horton, Peter J Huckfeldt, Sharon D Jackson, John M Jakicic, Robert W Jeffery, Karen C Johnson, Steven E Kahn, Tina Killean, William C Knowler, William C Knowler, Cora E Lewis, Nisa M Maruthur, Sara Michaels, Maria G Montez, David M Nathan, Jennifer Patricio, Anne Peters, Anne L Peters, Henry Pownall, Bruce Redmon, Julia T Rushing, Helmut Steinburg, Thomas A Wadden, Rena R Wing, Holly Wyatt, Susan Z Yanovski, null null
Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study. Diabetes care 44 (1) (2020)
Simon J Neuwahl, Xilin Zhou, Haiying Chen, Hui Shao, Michael Laxy, Andrea M Anderson, Timothy E Craven, Thomas J Hoerger, null null
Patient Health Utility Equations for a Type 2 Diabetes Model. Diabetes care 44 (2) (2020)
Stephen R Benoit, Ji Lin, Xiaohui Zhuo, Deborah B Rolka, Edward W Gregg, Xilin Zhou
Influence of Diabetes Complications on HbA1c Treatment Goals Among Older U.S. Adults: A Cost-effectiveness Analysis. Diabetes care 42 (11) (2019)
Sharon H Saydah, Sundar S Shrestha, Sundar S Shrestha, Xilin Zhou, Giuseppina Imperatore
Medical Costs Among Youth Younger Than 20 Years of Age With and Without Diabetic Ketoacidosis at the Time of Diabetes Diagnosis. Diabetes care 42 (12) (2019)